| Literature DB >> 24211266 |
Lucy C Young1, Nicole Hartig1, Marta Muñoz-Alegre1, Juan A Oses-Prieto2, Sevi Durdu3, Sabine Bender1, Vineetha Vijayakumar4, Matteo Vietri Rudan1, Christina Gewinner1, Stephen Henderson1, Amit P Jathoul1, Rupinder Ghatrora5, Mark F Lythgoe5, Alma L Burlingame2, Pablo Rodriguez-Viciana6.
Abstract
SHOC2 is mutated in Noonan syndrome and plays a key role in the activation of the ERK-MAPK pathway, which is upregulated in the majority of human cancers. SHOC2 functions as a PP1-regulatory protein and as an effector of MRAS. Here we show that SHOC2 and MRAS form a complex with SCRIB, a polarity protein with tumor suppressor properties. SCRIB functions as a PP1-regulatory protein and antagonizes SHOC2-mediated RAF dephosphorylation through a mechanism involving competition for PP1 molecules within the same macromolecular complex. SHOC2 function is selectively required for the malignant properties of tumor cells with mutant RAS, and both MRAS and SHOC2 play a key role in polarized migration. We propose that MRAS, through its ability to recruit a complex with paradoxical components, coordinates ERK pathway spatiotemporal dynamics with polarity and that this complex plays a key role during tumorigenic growth.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24211266 DOI: 10.1016/j.molcel.2013.10.004
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970